최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Neurology, v.55 no.10, 2000년, pp.1569 - 1572
Myhr, K.M. (From the Department of Neurology, Haukeland University Hospital (Drs. Myhr, Nyland, and Vedeler), University of Bergen, Norway) , Ross, C. (and the Institute for Inflammation Research (Drs. Ross and Bendtzen), Rigshospitalet University Hospital, Copenhagen, Denmark.) , Nyland, H.I. (From the Department of Neurology, Haukeland University Hospital (Drs. Myhr, Nyland, and Vedeler), University of Bergen, Norway) , Bendtzen, K. (and the Institute for Inflammation Research (Drs. Ross and Bendtzen), Rigshospitalet University Hospital, Copenhagen, Denmark.) , Vedeler, C.A. (From the Department of Neurology, Haukeland University Hospital (Drs. Myhr, Nyland, and Vedeler), University of Bergen, Norway)
초록이 없습니다.
Myhr, K.M., Riise, T., Lilleås, F.E. Green, Beiske, T.G., Celius, E.G., Edland, A., Jensen, D., Larsen, J.P., Nilsen, R., Nortvedt, M.W., Smievoll, A.I., Vedeler, C., Nyland, H.I.. Interferon-α2a reduces MRI disease activity in relapsing-remitting multiple sclerosis. Neurology, vol.52, no.5, 1049-1049.
Compston A. Treatment and management of MS. In: Compston A Ebers G Lassmann H McDonald I Matthews B Wekerle H eds. McAlpine’s MS. London: Churchill Livingstone 1998: 437-498.
Rudick, R. A., Simonian, N. A., Alam, J. A., Campion, M., Scaramucci, J. O., Jones, W., Coats, M. E., Goodkin, D. E., Weinstock-Guttman, B., Herndon, R. M., Mass, M. K., Richert, J. R., Salazar, A. M., Munschauer III, F. E., Cookfair, D. L., Simon, J. H., Jacobs, L. D.. Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Neurology, vol.50, no.5, 1266-1272.
Ross, C, Svenson, M, Hansen, M B, Vejlsgaard, G L, Bendtzen, K. High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG.. The Journal of clinical investigation, vol.95, no.5, 1974-1978.
Merup, M., Tornebohm-Roche, E., Engman, K., Paul, C.. Human leucocyte interferon-α therapy can induce a second response in treatment of thrombocytosis in patients with neutralising antibodies to recombinant interferon-α2a. European journal of cancer, vol.30, no.11, 1729-1730.
Khan, Omar A., Dhib-Jalbut, Suhayl S.. Neutralizing antibodies to interferon β-1a and interferon β-1b in MS patients are cross-reactive. Neurology, vol.51, no.6, 1698-1702.
Hennes, U., Jucker, W., Fischer, E.A., Krummenacher, T., Palleroni, A.V., Trown, P.W., Linder-Ciccolunghi, S., Rainisio, M.. The detection of antibodies to recombinant interferon alfa-2a in human serum. Journal of biological standardization, vol.15, no.3, 231-244.
FILES, JAMES G., GRAY, JULIA L., DO, LINH T., FOLEY, WAYNE P., GABE, JEFFREY D., NESTAAS, EIRIK, PUNGOR JR., ERNO. A Novel Sensitive and Selective Bioassay for Human Type I Interferons. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, vol.18, no.12, 1019-1024.
Rice, G.P. A., Paszner, B., Oger, J., Lesaux, J., Paty, D., Ebers, G.. The evolution of neutralizing antibodies in multiple sclerosis patients treated with interferon β-1b. Neurology, vol.52, no.6, 1277-1277.
THURMOND, L.M., REESE, M.J.. Differential Neutralizing Activity of Human Antibodies in Interferon Antiviral and Natural Killer Cell Bioassays. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, vol.17, no.10, 619-623.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.